1 results match your criteria: "Tom Baker Cancer Centre and Foothills Hospital[Affiliation]"

Twenty patients with Hodgkin's disease which had relapsed at least once after chemotherapy, were treated with melphalan 140-220 mg/m2 i.v. followed by reinfusion of non-cryopreserved autologous bone marrow.

View Article and Find Full Text PDF